Capital Markets Trading (UK)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Capital Markets Trading (UK)'s GILD Position: Q1 2022 in Review
Capital Markets Trading (UK) sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 5,518 shares — an estimated $353K sold.
Capital Markets Trading (UK) first reported a position in GILD in Q4 2017 and held it in 16 quarters. The position peaked at $8.05M in Q2 2018. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- Capital Markets Trading (UK) reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
- Capital Markets Trading (UK) sold 5,518 Gilead Sciences shares in Q1 2022, an estimated $353K.
- Capital Markets Trading (UK) first reported a position in Gilead Sciences in Q4 2017 and held it in 16 quarters.
- Capital Markets Trading (UK)'s Gilead Sciences position peaked at $8.05M in Q2 2018.
- 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on Capital Markets Trading (UK)'s 13F filing for Q1 2022, filed 16 May 2022.